|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7076 | |
| A61K 38/21 | |||
| A61P 25/00 |
| (11) | Number of the document | 2275110 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10182632.9 |
| Date of filing the European patent application | 2005-12-20 | |
| (97) | Date of publication of the European application | 2011-01-19 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 638669 P | 2004-12-22 | US | |
| 04106909 | 2004-12-22 | EP |
| (72) |
De Luca, Giampiero, CH
Ythier, Arnoud, CH
Munafo, Alain, CH
Lopez-Bresnahan, Maria, US
|
| (73) |
Merck Serono SA,
Centre Industriel, 1267 Coinsins, Vaud,
CH
|
| (54) | Cladribine regimen for treating Multiple Sclerosis |
| Cladribine regimen for treating Multiple Sclerosis |